AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 194 filers reported holding AMAG PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $152,000 | -35.6% | 10,000 | -15.2% | 0.01% | -9.1% |
| Q3 2018 | $236,000 | -39.5% | 11,796 | -41.0% | 0.01% | -38.9% |
| Q2 2018 | $390,000 | +93.1% | 20,000 | +100.0% | 0.02% | +80.0% |
| Q1 2018 | $202,000 | -62.8% | 10,000 | -66.1% | 0.01% | -61.5% |
| Q3 2017 | $543,000 | -15.9% | 29,500 | -16.0% | 0.03% | -16.1% |
| Q2 2017 | $646,000 | +1745.7% | 35,100 | +3410.0% | 0.03% | +1450.0% |
| Q4 2016 | $35,000 | -92.9% | 1,000 | -95.0% | 0.00% | -91.7% |
| Q3 2016 | $490,000 | -17.1% | 20,000 | -19.0% | 0.02% | -40.0% |
| Q2 2016 | $591,000 | +146.2% | 24,700 | +139.8% | 0.04% | +166.7% |
| Q1 2016 | $240,000 | -20.5% | 10,300 | +3.0% | 0.02% | -16.7% |
| Q4 2015 | $302,000 | +51.8% | 10,000 | +100.0% | 0.02% | +50.0% |
| Q3 2015 | $199,000 | – | 5,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 3,344,620 | $116,393,000 | 6.64% |
| Consonance Capital Management LP | 1,026,902 | $35,736,000 | 3.92% |
| FALCON POINT CAPITAL, LLC | 801,944 | $27,908,000 | 3.74% |
| Credit Capital Investments LLC | 72,813 | $2,534,000 | 3.24% |
| Crosspoint Capital Strategies, LLC | 99,274 | $3,455,000 | 3.07% |
| Camber Capital Management LP | 611,390 | $21,276,000 | 1.11% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 40,901 | $1,423,000 | 1.04% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 344,103 | $11,974,000 | 0.83% |
| STELLIAM INVESTMENT MANAGEMENT, LP | 572,500 | $19,923,000 | 0.66% |
| AlphaOne Investment Services, LLC | 66,105 | $2,301,000 | 0.64% |